Proposed insider sales of common stock

Reporting persons including Neil Kumar and related trusts reported proposed sales of Common stock under Rule 144.

Rhea-AI Filing Summary

Reporting persons including Neil Kumar and related trusts reported proposed sales of Common stock under Rule 144. The filing lists multiple 10b5-1 scheduled sales between 11/20/2025 and 02/16/2026, including examples of NEIL KUMAR 30,011 shares and KUMAR HALDEA REVOCABLE TRUST 20,000 shares. The securities are Common stock held at Morgan Stanley Smith Barney LLC.

Insights

Securities Attorney

Rule 144/Form 144 notices list proposed affiliate sales under prearranged 10b5-1 plans.

The filing names reporting persons and multiple proposed dispositions of Common stock, with specific trade dates such as 12/15/2025 and 02/11/2026

Execution depends on plan terms and broker handling; subsequent Form 4/Form 5 or trade confirmations will show completed transactions and actual proceeds.

FAQ

What does the BBIO Form 144 disclose?

It discloses proposed affiliate sales of Common stock under Rule 144. The filing lists multiple 10b5-1 scheduled sales dated between 11/20/2025 and 02/16/2026, with per-trade examples like 30,011 and 20,000 shares.

Who are the reported sellers in the BBIO filing?

Reported sellers include Neil Kumar and related trusts. The entries show sales by NEIL KUMAR and by KUMAR HALDEA REVOCABLE and FAMILY IRREVOCABLE TRUSTS at a Morgan Stanley Smith Barney LLC account.

Are the sales in the BBIO Form 144 completed?

No—Form 144 reports proposed or intended affiliate sales, not final trades. The filing lists scheduled 10b5-1 sales and dates; actual completion and proceeds require subsequent transaction records.

What sizes of sales are shown in the BBIO filing?

Individual scheduled sales range from 20,000 to 30,011 shares in the excerpt. Examples include NEIL KUMAR 30,011 shares on 12/15/2025 and multiple 20,000-share entries for affiliated trusts in early 2026.

Which broker or account handled the securities in the filing?

The securities are held at Morgan Stanley Smith Barney LLC. The filing lists the broker and an account address for the affected Common shares associated with the reported sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:22 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001742485
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BridgeBio Pharma, Inc.
SEC File Number	001-38959
Address of Issuer	3160 PORTER DRIVE SUITE 250 Palo Alto CALIFORNIA 94304
Phone	6503919740
Name of Person for Whose Account the Securities are To Be Sold	NEIL KUMAR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	28053	2073958.29	192708813	02/19/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/16/2026	Restricted Stock Units	Issuer			28053	02/16/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	02/11/2026	20000	1435544.00
10b5-1 Sales for KUMAR HALDEA FAMILY IRREVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	02/11/2026	20000	1435542.00
10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	02/10/2026	20000	1438758.00
10b5-1 Sales for KUMAR HALDEA FAMILY IRREVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	02/10/2026	20000	1438822.00
10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	01/09/2026	20000	1542114.00
10b5-1 Sales for KUMAR HALDEA FAMILY IRREVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	01/09/2026	20000	1542198.00
10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	01/08/2026	20000	1479432.00
10b5-1 Sales for KUMAR HALDEA FAMILY IRREVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	01/08/2026	20000	1479422.00
10b5-1 Sales for NEIL KUMAR 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	12/15/2025	30011	2239901.00
10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	12/05/2025	20000	1466288.00
10b5-1 Sales for KUMAR HALDEA FAMILY IRREVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	12/05/2025	20000	1466276.00
10b5-1 Sales for KUMAR HALDEA REVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	12/04/2025	20000	1487954.00
10b5-1 Sales for KUMAR HALDEA FAMILY IRREVOCABLE TRUST 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	12/04/2025	20000	1487958.00
10b5-1 Sales for NEIL KUMAR 3160 PORTER DRIVE SUITE 250 Palo Alto CA 94304	Common	11/20/2025	26156	1722223.51

144: Remarks and Signature

Remarks
Date of Notice	02/19/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/31/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Neil Kumar
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)